Traumatic Brain Injuries Treatment Market Overview:
Traumatic brain injury (TBI) occurs from a violent
blow or head injury that disturb the normal functioning of the brain. Every
year TBI contributes to a substantial number of death and permanent disability.
Elder age population holds the largest share of global traumatic brain injuries
treatment market due to increasing incidence of road accident and high rate of
hospitalization and is expected to grow staidly during the forecast period.
Whereas based on treatment, medication (drug) segment holds the highest share
of this market. Increasing incidences of road traffic injury and the government
initiatives to fund for traumatic brain injuries project will boost the
traumatic brain injuries treatment market during assessment period.
Traumatic Brain Injuries Treatment market size was valued at USD 1.84 Billion in 2023. The
traumatic brain injuries treatment industry is projected to grow from USD 1.99
Billion in 2024 to USD 3.54 Billion by 2032, exhibiting a compound annual
growth rate (CAGR) of 7.42% during the forecast period (2024 - 2032)
Latest Innovation on Traumatic Brain Injuries
Treatment Market
1. Stem Cell Therapy for Brain Repair
Innovations in the treatment of traumatic brain
injuries (TBI) include the use of stem cell therapy to promote brain repair and
regeneration. Researchers are exploring the potential of stem cells to replace
damaged neurons, reduce inflammation, and stimulate the growth of new brain
tissue, offering hope for improved recovery outcomes in TBI patients.
2. Neuroprotective Drugs and Nanotechnology
Recent advancements have led to the development of
neuroprotective drugs that aim to minimize brain damage after a traumatic
injury. These drugs, often delivered using nanotechnology, target specific
brain areas to reduce inflammation and oxidative stress, and protect neurons
from further damage. This targeted approach enhances the effectiveness of
treatment and reduces side effects, potentially improving the quality of life
for TBI patients.
However, high cost of treatment and devices may
hamper the growth of global traumatic brain injuries treatment market during the forecast period.
The global traumatic brain injuries treatment
market is dominated by many market players. The key players in the market are
engaged in new launches of drug and devices to maintain the strategic collaborations
to hold its market position. Recently the US FDA has approved the blood test to
diagnose the traumatic brain injury.
Traumatic
Brain Injuries (TBI) Treatment Market Players
The Global Traumatic brain injuries treatment
market players are Neuren Pharmaceuticals Ltd., Oxygen Biotherapeutics Inc,
Ischemic, Grace Laboratories LLC. Cognosci, Medicortex, Amarantus BioScience
Holdings, Aldagen, TEVA Pharmaceutical Industries Ltd., NeuroScience
Pharmaceuticals, Targacept, BioDirection, Inc., QuesGen Systems, Inc.,
BrainScope Company, Inc., Oculogica, BrainScope Company, Inc, Vasopharm GmbH,
Silver Creek Pharmaceuticals Inc, Stemedica Cell Technologies Inc, Neural
Analytics Inc, Banayan Biomarkers Inc, Zimmer Biomet.
Traumatic Brain Injuries Treatment Market Regional
Analysis:
The market in the Americas is expected to dominate
the global traumatic brain injuries treatment market during the forecast period
owing to the increasing incidences of road traffic injuries and increasing
hospitalization of geriatric population due to TBI. Additionally, the growing
incidences of road traffic collision associated with the aging population are
anticipated to boost the growth of the market in this region. Whereas North
America holds the highest share of global traumatic brain injury treatment due
to increasing number of TBI patients and increasing investment by government in
research and development activity on diagnosis management.
The European market is expected to be the
second-largest due to government funding and support of the healthcare sector
coupled with the growing incidence of elderly patients, increasing incidences
of road traffic collision and funding by the government for traumatic brain
injury project. Moreover, the market in Asia-Pacific is anticipated to be the
fastest-growing during the assessment period owing to growing number of
neurological canters and increasing incidences of road accident. The market in
the Middle East & Africa is likely to account for the smallest share of
this market. The market growth in this region can be attributed to increasing
healthcare expenditure and developing healthcare infrastructure.
Traumatic Brain Injuries Treatment Market Segmentation:
Global traumatic brain injuries treatment market outlook is further segmented into treatment types and
end-users.
Based on treatment types of the market is segmented
into immediate emergency care, medications, surgery. On basis of medication global traumatic
brain injuries treatment market is further sub-segmented into diuretics,
anti-seizure drugs, coma-inducing drugs, anti-anxiety agent, anti-depressants,
anti-psychotics, analgesic, anti-convulsant and anti-coagulants.
Based on brain surgery equipment, TBI market is further sub-segmented into removing
clotted blood (hematomas), repairing skull fractures, bleeding in the brain,
opening a window in the skull, rehabilitation.
On basis of end-users global TBI market is further
segmented into hospitals, neurologist, rehabilitative canter treatment,
independent pharmacies, and others.
Related Trending Reports-
Stem Cell Manufacturing market
No comments:
Post a Comment